| abstract |
Methods of modulating cytokine levels in a human subject by administering interferon-tau (IFN.tau.) are described. More specifically, a method of up-regulating the interleukin 10 (IL-10) level in patients afflicted with a condition that responds to treatment by having an increased blood IL-10 level, such as an autoimmune condition, a viral infection, or a condition of cellular proliferation by administering IFN.tau. is described. Also described are methods of modulating blood levels of interleukin-12 (IL-12) and interferon-gamma (IFN-.gamma.) by administering IFN.tau.. In various embodiments, IFN.tau. is administered alone or in combination with a second therapeutic agent. |